Concepedia

Gonadotropin-releasing hormone agonists, anti-androgens and the risk of cardio-cerebrovascular disease in prostate cancer patients: an asian population-based observational study

Jong-Mi Seong, Jae Woo Sung, Shinjay Cho, Jonghyup Yang, Sungmin Kang, Hyong Woo Moon, Kyu Won Lee, U‐Syn Ha

Journal of Cancer · 2020 · 12 citations · 15 references

DOIFull text

Open access

Concepts

Abstract

Purpose: To conduct a population-based study to determine whether the use of GnRH agonist and antiandrogens are associated with an increased risk of cardio-cerebrovascular disease (CCVD) in Asian patients with prostate cancer using the National Health Insurance Service-Elderly Cohort Database (NHIS-ECD).

References

15

Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data

Hude Quan, Vijaya Sundararajan, Patricia Halfon et al. · Medical Care · 2005 · 10.6K citations

, , +16

Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk

Glenn N. Levine, Anthony V. D’Amico, Peter Berger et al. · Circulation · 2010 · 376 citations · Full text

, , +16

Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist

Peter C. Albertsen, Laurence Klotz, Bertrand Tombal et al. · European Urology · 2013 · 338 citations

, , +14

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.

Ann W. Hsing, Yu‐Tang Gao, Guan Wu et al. · PubMed · 2000 · 315 citations

, , +17

Physiological Testosterone Replacement Therapy Attenuates Fatty Streak Formation and Improves High-Density Lipoprotein Cholesterol in the Tfm Mouse

Joanne E. Nettleship, Tineke H. Jones, Kevin S. Channer et al. · Circulation · 2007 · 119 citations · Full text

, , +17